# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Adult spinal muscular atrophy

Adult proximal spinal muscular atrophy autosomal dominant
Get Update

Review Articles from PubMed

Review articles summarize what is currently known about a disease. They discuss research previously published by others. The terms "Adult spinal muscular atrophy" returned 0 free, full-text review articles. First 0 results:
Adult-onset spinal muscular atrophy: An update.
Last Updated: Mar 19, 2018

Spinal muscular atrophy (SMA) refers to a group of disorders affecting lower motor neurons. The age of onset of these disorders is variable, ranging from the neonatal period to adulthood. Over the last few years, there has been enormous progress in the description of new genes and ...

Full PubMed Review articles matches at NCBI:
0 Free Review Articles 1 Review Articles

Editorials from PubMed

Editorial articles describe the outcome of a single study. They are the published results of original research. The terms "Adult spinal muscular atrophy" returned 1 free, full-text editorial articles. First 1 results:
Full PubMed Editorials matches at NCBI:
1 Free Editorials

Research Articles from PubMed

Research articles describe the outcome of a single study. They are the published results of original research. The terms "Adult spinal muscular atrophy" returned 7 free, full-text research articles. First few results:
[Spinal Muscular Atrophy - expert recommendations for the use of nusinersen in adult patients].
Last Updated: Dec 19, 2019

With Nusinersen, a first causative treatment for 5q-associated spinal muscular atrophy (SMA) has been available in Europe since 2017. Real-world data from neuromuscular clinical centers in Germany increasingly show a therapeutic benefit of nusinersen also in adult SMA patients of ...

Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with Nusinersen.
Last Updated: Mar 23, 2020

Nusinersen is the first approved drug for the treatment of spinal muscular atrophy (SMA). Treatment of SMA with nusinersen is based on a fixed dosing regimen. For other motoneuron diseases, such as amyotrophic lateral sclerosis (ALS), biomarkers are available for clinical diagnostics; ...

Full PubMed Research articles matches at NCBI:
7 Free Research Articles 40 Research Articles